Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sangui Biotech International, Inc. SGBI

Full chart Compare
Set alert

Price alert · SGBI

All alert types
0.00 0.00 (+0.00%)

At closeJul 2, 2025, 4:00 PM EDT

0.0002 Day range 0.0015

52-week range unavailable

Financial health

Altman Z-Score

-342.52 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -15.0×
FY 2015: -12.5×FY 2016: -1.6×FY 2017: -18.2×FY 2018: -13.6×FY 2019: -10.6×FY 2020: -12.9×FY 2021: -21.3×FY 2022: -33.3×FY 2023: -5.0×FY 2024: -15.0×
FY 2015 5y median -15.0× FY 2024
P/S 2.4×
FY 2015: 68.6×FY 2016: 13.9×FY 2017: 81.8×FY 2018: 36.6×FY 2019: 38.1×FY 2020: 90.4×FY 2021: 79.7×FY 2022: 30.1×FY 2023: 7.9×FY 2024: 2.4×
FY 2015 5y median 30.1× FY 2024
P/B -0.8×
FY 2015: 39.1×FY 2016: 2.0×FY 2017: 15.9×FY 2018: 10.4×FY 2019: 68.1×FY 2020: -31.5×FY 2021: -23.4×FY 2022: -8.7×FY 2023: -1.9×FY 2024: -0.8×
FY 2015 5y median -8.7× FY 2024
P/FCF 10.1×
FY 2015: -14.5×FY 2016: -1.7×FY 2017: -17.1×FY 2018: -11.1×FY 2019: -10.6×FY 2020: -15.2×FY 2021: -35.8×FY 2022: -14.9×FY 2023: -63.1×FY 2024: 10.1×
FY 2015 5y median -15.2× FY 2024
EV/EBITDA -746×
FY 2015: -11.9×FY 2016: -2.7×FY 2017: -1565×FY 2018: 5549×FY 2019: 559×FY 2020: -18.3×FY 2021: -32.6×FY 2022: -128×FY 2023: -21.1×FY 2024: -746×
FY 2015 5y median -32.6× FY 2024
EV/Sales 8.0×
FY 2015: 70.0×FY 2016: 15.5×FY 2017: 83.2×FY 2018: 39.5×FY 2019: 43.2×FY 2020: 114×FY 2021: 91.9×FY 2022: 41.6×FY 2023: 16.8×FY 2024: 8.0×
FY 2015 5y median 41.6× FY 2024
FCF Yield 9.9%
FY 2015: -6.9%FY 2016: -59.3%FY 2017: -5.8%FY 2018: -9.0%FY 2019: -9.5%FY 2020: -6.6%FY 2021: -2.8%FY 2022: -6.7%FY 2023: -1.6%FY 2024: 9.9%
FY 2015 5y median -2.8% FY 2024

Profitability

Gross Margin 100.0%
FY 2015: 99.6%FY 2016: 99.4%FY 2017: 99.0%FY 2018: 97.8%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%
FY 2015 5y median 100.0% FY 2024
Operating Margin -1.3%
FY 2015: -590.2%FY 2016: -751.7%FY 2017: -468.3%FY 2018: -269.7%FY 2019: -383.7%FY 2020: -627.3%FY 2021: -230.4%FY 2022: -201.5%FY 2023: -94.7%FY 2024: -1.3%
FY 2015 5y median -201.5% FY 2024
Net Margin -9.1%
FY 2015: -552.8%FY 2016: -879.6%FY 2017: -456.7%FY 2018: -261.6%FY 2019: -367.7%FY 2020: -666.6%FY 2021: -359.8%FY 2022: -85.7%FY 2023: -158.8%FY 2024: -9.1%
FY 2015 5y median -158.8% FY 2024
ROE 3.1%
FY 2015: -315.0%FY 2016: -124.2%FY 2017: -88.9%FY 2018: -74.4%FY 2019: -657.6%FY 2020: 232.5%FY 2021: 105.6%FY 2022: 24.8%FY 2023: 38.7%FY 2024: 3.1%
FY 2015 5y median 38.7% FY 2024
ROIC 0.6%
FY 2015: 528.6%FY 2016: 366.5%FY 2017: 295.3%FY 2018: 194.8%FY 2019: 297.1%FY 2020: 726.6%FY 2021: 349.3%FY 2022: 199.3%FY 2023: 42.6%FY 2024: 0.6%
FY 2015 5y median 199.3% FY 2024
ROA -14.4%
FY 2015: -577.2%FY 2016: -382.4%FY 2017: -329.5%FY 2018: -197.8%FY 2019: -409.7%FY 2020: -153.8%FY 2021: -175.9%FY 2022: -45.3%FY 2023: -162.4%FY 2024: -14.4%
FY 2015 5y median -153.8% FY 2024

Growth (YoY)

Revenue 43.3%
FY 2015: -4.5%FY 2016: -62.3%FY 2017: 40.9%FY 2018: 14.0%FY 2019: 14.1%FY 2020: -67.1%FY 2021: 126.8%FY 2022: 5.5%FY 2023: 34.5%FY 2024: 43.3%
FY 2015 FY 2024
Operating Income 98.0%
FY 2015: 42.9%FY 2016: 52.0%FY 2017: 12.2%FY 2018: 34.3%FY 2019: -62.3%FY 2020: 46.3%FY 2021: 16.7%FY 2022: 7.7%FY 2023: 36.8%FY 2024: 98.0%
FY 2015 FY 2024
EPS (diluted) 85.7%
FY 2015: 53.8%FY 2016: 43.7%FY 2017: 37.0%FY 2018: 35.3%FY 2019: -45.5%FY 2020: 37.5%FY 2021: -20.0%FY 2022: 75.0%FY 2023: -133.3%FY 2024: 85.7%
FY 2015 FY 2024
Free Cash Flow 368.9%
FY 2015: 20.8%FY 2016: 34.5%FY 2017: 18.2%FY 2018: 21.5%FY 2019: -24.9%FY 2020: 45.9%FY 2021: 15.0%FY 2022: 3.7%FY 2023: 91.7%FY 2024: 368.9%
FY 2015 FY 2024

Financial Health

Current Ratio 0.1×
FY 2015: 0.2×FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×
FY 2015 5y median 0.1× FY 2024
Quick Ratio 0.1×
FY 2015: 0.2×FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×
FY 2015 5y median 0.1× FY 2024
Debt / Equity -1.9×
FY 2015: 0.9×FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.9×FY 2019: 9.7×FY 2020: -8.5×FY 2021: -3.7×FY 2022: -3.5×FY 2023: -2.2×FY 2024: -1.9×
FY 2015 5y median -3.5× FY 2024
Net Debt / EBITDA -527×
FY 2015: -0.2×FY 2016: -0.3×FY 2017: -26.8×FY 2018: 407×FY 2019: 66.2×FY 2020: -3.8×FY 2021: -4.3×FY 2022: -35.4×FY 2023: -11.2×FY 2024: -527×
FY 2015 5y median -11.2× FY 2024
Interest Coverage -0.1×
FY 2015: -123×FY 2016: -5.2×FY 2017: -34.4×FY 2018: -25.0×FY 2019: -28.9×FY 2020: -12.9×FY 2021: -8.4×FY 2022: -7.2×FY 2023: 0.0×FY 2024: -0.1×
FY 2015 5y median -7.2× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-06-30